FDA cleared Meridian Bioscience’s illumingene® molecular diagnostic test for Group A Streptococcus pharyngitis. The test, carried out on the illumigene molecular diagnostic platform, uses ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback